A Review on the Protective Mechanisms of Taurine in Acute Lung Injury Via the S1P/S1PR1 Signaling Pathway

DOI: https://doi.org/10.62517/jmhs.202505209

Author(s)

Li Rongsheng, Zhu Xiulian*

Affiliation(s)

Animal Laboratory, The 924th Hospital of the Joint Logistics Support Force of Chinese PLA, Guilin, Guangxi, China *Corresponding author

Abstract

This review summarises the mechanisms and progress of taurine in alleviating acute lung injury (ALI) by regulating the S1P/S1PR1 signaling pathway. It introduces the biological functions of the S1P/S1PR1 pathway. S1P is a bioactive compound derived from sphingolipid metabolism. By binding to S1PR, it performs various cellular functions and is crucial for regulating vascular barrier function and inflammatory responses. The review also describes the properties of taurine and its protective effects in ALI, including its anti - inflammatory, antioxidant features, and the protection of alveolar epithelial barriers. Emphasis is placed on the interaction between taurine and the S1P/S1PR1 pathway, such as how taurine regulates SphK1/S1P synthesis through its antioxidant capacity and produces a synergistic effect with S1PR1 activators. Finally, future research directions are proposed, including the elucidation of molecular mechanisms, optimisation of dosing regimens, development of combination therapies, and validation of clinical translation. The aim is to provide new strategies for the treatment of ALI.

Keywords

Acute Lung Injury; Taurine; S1P/S1PR1 Signaling Pathway

References

[1] Abedi F, Hayes A W, Reiter R, et al. Acute lung injury: The therapeutic role of Rho kinase inhibitors[J]. Pharmacol Res, 2020,155:104736. [2] Zheng J, Li Y, Kong X, et al. Exploring immune-related pathogenesis in lung injury: Providing new insights Into ALI/ARDS[J]. Biomed Pharmacother, 2024,175:116773. [3] Peng X, Hassoun P M, Sammani S, et al. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury[J]. Am J Respir Crit Care Med, 2004,169(11):1245-1251. [4] Harijith A, Pendyala S, Ebenezer D L, et al. Hyperoxia-induced p47phox activation and ROS generation is mediated through S1P transporter Spns2, and S1P/S1P1&2 signaling axis in lung endothelium[J]. Am J Physiol Lung Cell Mol Physiol, 2016,311(2):L337-L351. [5] Al-Kuraishy H M, Batiha G E, Al-Gareeb A I, et al. Receptor-dependent effects of sphingosine-1-phosphate (S1P) in COVID-19: the black side of the moon[J]. Mol Cell Biochem, 2023,478(10):2271-2279. [6] Mai J, He Q, Liu Y, et al. Hyperoside Attenuates Sepsis-Induced Acute Lung Injury (ALI) through Autophagy Regulation and Inflammation Suppression [J]. Mediators of Inflammation, 2023, 2023: 1-9. [7] Xiao P, SunS, Cao J, et al. Expression profile of microRNAs in bronchoalveolar lavage fluid of rats as predictors for smoke inhalation injury [J]. Burns, 2018, 44(8): 2042-2050. [8] He YQ, Zhou CC, Yu LY, et al. Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms [J]. Pharmacol Res, 2021, 163: 105224. [9] Mai J, He Q, Liu Y, et al. Hyperoside Attenuates Sepsis-Induced Acute Lung Injury (ALI) through Autophagy Regulation and Inflammation Suppression [J]. Mediators of Inflammation, 2023, 2023: 1-9. [10] Deng M, Du S, Hou H, et al. Structural insights into the high-affinity IgE receptor FcepsilonRI complex[J]. Nature, 2024,633(8031):952-959. [11] Crosson T, Wang J, Doyle B, et al. FcepsilonR1-expressing nociceptors trigger allergic airway inflammation[J]. J Allergy Clin Immunol, 2021,147(6):2330-2342. [12] Terlizzi M, Falanga A, Colarusso C, et al. Sphingosine-1-Phosphate Shapes Healthy Monocytes into An Immunosuppressive Phenotype[J]. Cell Physiol Biochem, 2024,58(2):156-171. [13] Jo H, Shim K, Jeoung D. The Crosstalk between FcepsilonRI and Sphingosine Signaling in Allergic Inflammation[J]. Int J Mol Sci, 2022,23(22). [14] Lu Q, Liu J, Yu Y, et al. ALB, HP, OAF and RBP4 as novel protein biomarkers for identifying cured patients with pulmonary tuberculosis by DIA[J]. Clin Chim Acta, 2022,535:82-91. [15] Yang F, Haile D J, Berger F G, et al. Haptoglobin reduces lung injury associated with exposure to blood[J]. Am J Physiol Lung Cell Mol Physiol, 2003,284(2):L402-L409. [16] Yang F, Friedrichs W E, Navarijo-Ashbaugh A L, et al. Cell type-specific and inflammatory-induced expression of haptoglobin gene in lung[J]. Lab Invest, 1995,73(3):433-440. [17] Silva-Santos B, Mensurado S, Coffelt S B. gammadelta T cells: pleiotropic immune effectors with therapeutic potential in cancer[J]. Nat Rev Cancer, 2019,19(7):392-404. [18] Papotto P H, Ribot J C, Silva-Santos B. IL-17(+) gammadelta T cells as kick-starters of inflammation[J]. Nat Immunol, 2017,18(6):604-611. [19] Huang Y, Chen X, Liu X, et al. The coumarin component isofraxidin targets the G-protein-coupled receptor S1PR1 to modulate IL-17 signaling and alleviate ulcerative colitis[J]. Int Immunopharmacol, 2024,131:111814.